Member Info for Magsy18

Absolutely no idea. Same as you guys.

You know another great thing about graphs? You can take different date ranges to back up any point you like, be it positive or negative.

This share barely follows the technical analysis of experts who go into depth. So why would your naïve 'technical analysis' provide any insight at all?

You were all saying the same things last month when we were in the 140s before we retraced back to 100p.

In the past month we have moved up and down between 100p and 150p and all through that people have been using the 'NT to buy' and 'NT to sell' BS as a reason why the share price is about to rocket.

People here have demonstrated repeatedly that they know absolutely nothing about where this share price is going.

You have hit the nail on the head here. What happens prior to approvals/sales is largely irrelevant.

Ironically, in general, it's the LTHs here that are most interested in the short term movements of the share price.

Hmm, AIM company CEOs resigning when they have spent all the cash/and or have not performed?

Now there's a novel idea!

If there were decent sales then they would be reporting it for two reasons. One, they are bound to release price sensitive information which initial sales would certainly be. Two, they would want to share this success with shareholders, out of respect for them.

Anybody who claims that news is being 'saved up' so it can all be released at once is, quite frankly, lying.

DrM, I agree that something doesn't feel quite right but I will see it out. I can't see us not getting approved and when they come, if nothing else, should provide a spike upwards which may present people with an opportunity to exit.

I don't you, me or probably anyone on the board is aware of all of the dynamics regarding reasons why a good product isn't selling. So while you might be right, price could be an issue, I think claiming that it's the only realistic reason is probably a bit of an argument from ignorance.

If I didn't believe there was profit to be made here, I would of course sell but I think the potential of getting anywhere near NCYT is long gone.

Ok so the EE stuff we can completely disregard because the source is not verifiable nor has any reputable source reported it.
And the India stuff - Twitter? LOL

I mean, I am not particularly positive about GDR right now but come on DrM, you can do better than this.

Where did you originally read about a potential EE deal? Where are you reading about no India deal?

Prior to their recent rise, NCYT were stuck sub £3 for quite some time. Despite being ahead of GDR by a number of months and also being partnered with a major pharma, no take over.

When it comes to take over, I look at NCYT and wonder why they wouldn't have been taken over if companies were really that interested.

Thanks for clarification Technick, congrats on a nice bit of trading there!

Technick, you have sold out twice and bought back into GDR twice in the last few months. Can you clarify whether you sold your entire holding or just part of it each time?

I guess we don't know.

When they converted, the usual crowd were saying how it's great news as they must know something is coming! I imagine BGF selling is also great news in some way too, waiting to hear that one.

BGF will be converting the rest of their loan note at some point which will add a further 6.7million shares. Maybe they are just clearing the decks prior to that?

Oh be quiet. You used up all your 'major RNS coming soon' tokens a few weeks ago.

The current price is around £2.20 old money so we are hovering around the highs back in May.

You’ll never be selling then. Which is great for the rest of us.

Another beauty regarding NCYT was from one of the posters here called RollingInit. He claimed back in May that the NCYT profit margin on tests was next to zero. Whoops. One of many, many bloopers from that guy.

https://suite.endole.co.uk/explorer/postcode/m13-9xx

Here’s a bunch of other, unrelated, companies who have the same address. Interesting...

MOIL says Epistem use GDR tests.
Epistem themselves say they don’t use GDR tests.

End of story, MOIL is a liar.